Global Health · NSE: MEDANTA · BSE: 543654
Q4 FY24 results · Jan–Mar 2024
Global Health reported revenue from operations of ₹808.63 crore (up 15.0% from Q4 FY23) and net profit of ₹127.35 crore (up 26.0% from Q4 FY23) for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 808.63 | 703.42 | +15.0% | 832.60 | −2.9% |
| Other income | 27.42 | 28.41 | −3.5% | 21.93 | +25.0% |
| Total income | 836.05 | 731.83 | +14.2% | 854.53 | −2.2% |
| Profit before tax | 143.09 | 133.08 | +7.5% | 172.36 | −17.0% |
| Net profit for the period | 127.35 | 101.07 | +26.0% | 123.54 | +3.1% |
| Attributable to shareholders of the company | 127.38 | — | — | 123.64 | +3.0% |
| EPS, basic (₹) | 4.74 | 3.77 | +25.7% | 4.61 | +2.8% |
| Net margin (%) | 15.7 | 14.4 | 14.8 |
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 578.64 | 502.91 | +15.1% | 561.68 | +3.0% |
| Other income | 32.55 | 28.10 | +15.8% | 25.83 | +26.0% |
| Total income | 611.19 | 531.01 | +15.1% | 587.51 | +4.0% |
| Profit before tax | 125.17 | 104.19 | +20.1% | 120.87 | +3.6% |
| Net profit for the period | 92.24 | 80.96 | +13.9% | 87.34 | +5.6% |
| EPS, basic (₹) | 3.43 | 3.02 | +13.6% | 3.25 | +5.5% |
| Net margin (%) | 15.9 | 16.1 | 15.6 |
Consolidated
- Filed with BSE
- 18 May 2024, 09:19 IST
- Board meeting
- 17 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 18 May 2024, 09:19 IST
- Board meeting
- 17 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE